Nuchal translucency and cardiac abnormalities in euploid singleton pregnancies

References

• van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011;15;58:2241–7. Review
   PubMedGoogle Scholar
• Westin M, Saltvedt S, Bergman G, et al. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16 383 fetuses. Ultrasound Obstet Gynecol 2006;27:632–9. Review
   PubMed Web of Science ®Google Scholar
• Simpson LL, Malone FD, Bianchi DW, et al. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007;109:376–83
   PubMed Web of Science ®Google Scholar
• Bahado-Singh RO, Wapner R, Thom E, et al. First trimester maternal serum biochemistry and fetal nuchal translucency screening study group. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 2005;192:1357–61
   PubMed Web of Science ®Google Scholar
• Mogra R, Alabbad N, Hyett J. Increased nuchal translucency and congenital heart disease. Early Hum Dev 2012;88:261–7
   PubMedGoogle Scholar
• Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ 1999;318:81–5
   PubMed Web of Science ®Google Scholar
• Mavrides E, Cobian-Sanchez F, Tekay A, et al. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17:106–10
   PubMedGoogle Scholar
• Makrydimas G, Sotiriadis A, Ioannidis JP. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 2003;189:1330–5
   PubMed Web of Science ®Google Scholar
• Makrydimas G, Sotiriadis A, Huggon IC, et al. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005;192:89–95
   PubMed Web of Science ®Google Scholar
• Orvos H, Wayda K, Kozinszky Z, et al. Increased nuchal translucency and congenital heart defects in euploid fetuses: the Szeged experience. Eur J Obstet Gynecol Reprod Biol 2002;101:124–8
   PubMedGoogle Scholar
• Hafner E, Schuller T, Metzenbauer M, et al. Increased nuchal translucency and congenital heart defects in a low-risk population. Prenat Diagn 2003;23:985–9
   PubMedGoogle Scholar
• Hoffman JI, Christian R. Congenital heart disease in a cohort of 19 502 births with long-term follow-up. Am J Cardiol 1978;42:641–7
   PubMed Web of Science ®Google Scholar
• Carvalho JS, Mavrides E, Shinebourne EA, et al. Improving the effectiveness of routine prenatal screening for major heart defects. Heart 2002;88:387–91
   PubMed Web of Science ®Google Scholar
• Wald NJ, Morris JK, Walker K, Simpson JM. Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis. Prenat Diagn 2008;28:1094–104. Review
   PubMed Web of Science ®Google Scholar
• Sananes N, Guigue V, Kohler M, et al. Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12 910 euploid pregnancies. Ultrasound Obstet Gynecol 2010;35:273–9
   PubMedGoogle Scholar
• Ghi T, Huggon IC, Zosmer N, Nicolaides KH. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001;18:610–14
   PubMed Web of Science ®Google Scholar
• Müller MA, Clur SA, Timmerman E, Bilardo CM. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies. Prenat Diagn 2007;27:164–9
   PubMed Web of Science ®Google Scholar
• Clur SA, Ottenkamp J, Bilardo CM. The nuchal translucency and the fetal heart: a literature review. Prenat Diagn 2009;29:739–48. Review
   PubMed Web of Science ®Google Scholar
• American Institute of Ultrasound in Medicine. AIUM Practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med 2010;29:157–66
   PubMedGoogle Scholar
• Hyett JA, Perdu M, Sharland GK, et al. Increased nuchal translucency at 10–14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997;10:242–6
   PubMed Web of Science ®Google Scholar
• Josefsson A, Molander E, Selbing A. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination. Acta Obstet Gynecol Scand 1998;77:497–9
   PubMedGoogle Scholar
• Bilardo CM, Pajkrt E, de Graaf I, et al. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998;11:401–6
   PubMed Web of Science ®Google Scholar
• Schwarzler P, Carvalho JS, Senat MV, et al. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency measurement at 10–14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999;106:1029–34
   PubMedGoogle Scholar
• Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001;17:102–5
   PubMed Web of Science ®Google Scholar
• Bruns RF, Moron AF, Murta CG, et al. The role of nuchal translucency in the screening for congenital heart defects. Arq Bras Cardiol 2006;87:307–14
   PubMedGoogle Scholar
• Muller MA, Clur SA, Timmerman E, Bilardo CM. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies. Prenat Diagn 2007;27:164–9
   PubMed Web of Science ®Google Scholar